Global Neurology Academy - Global Neurology Academy

Global Neurology Academy

Global Neurology Academy

Enhance your practice with CME
and tools that focus on the management
of neurological conditions.

Popular

Precision Medicine for Myasthenia Gravis
Precision Medicine for Myasthenia Gravis
NeuroFrontiers
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
The New Era of Targeted Therapy for Myasthenia Gravis
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiers
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Immunologic Phenotyping: The Future of Personalized MG Care
NeuroFrontiers
Immunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
Navigating Emerging Treatment Options in MG
Navigating Emerging Treatment Options in MG
NeuroFrontiers
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
- Qihua Fan, MD
New Therapies, New Strategy: Rethinking MG Inpatient Care
New Therapies, New Strategy: Rethinking MG Inpatient Care
NeuroFrontiers
New Therapies, New Strategy: Rethinking MG Inpatient Care
Qihua Fan, MD
- Qihua Fan, MD
CME/CE In-Person Event
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
1.00 credit
Outcome Measures Capture Progression in Late-Onset TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
NeuroFrontiers
Outcome Measures Capture Progression in Late-Onset TK2d
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
AudioAbstracts
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
- Ryan Quigley

Medical News

Medical News
Race, Stroke Belt, and Cerebral Microbleeds After Stroke
10/05/2026
Read more
Medical News
Parkinson's AI Chatbot Misses Critical Safety Errors
10/01/2026
Read more
Medical News
Japanese Study Reveals Treatment‐Resistant Schizophrenia Prevalence in Inpatients
09/29/2026
Read more
Medical News
MRgFUS Thalamotomy Improves Parkinson Tremor at 6 Months
09/23/2026
Read more

CME/CE

The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
Recurrence as the Rule: BD Symptoms Persist and Cycle
Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
Navigating the Limitations of Current BD Therapies
Navigating the Limitations of Current BD Therapies
MinuteCE®
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
MinuteCE®
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 credits 5 episodes
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 credits 5 episodes

Clinical Practice

ADHD After 25 Years: What Have We Learned?
ADHD After 25 Years: What Have We Learned?
NeuroFrontiers
ADHD After 25 Years: What Have We Learned?
James Swanson, PhD
- James Swanson, PhD
What’s Still Missing in ADHD Care?
What’s Still Missing in ADHD Care?
NeuroFrontiers
What’s Still Missing in ADHD Care?
James Swanson, PhD
- James Swanson, PhD
Diagnosing Adult ADHD in the Social Media Era
Diagnosing Adult ADHD in the Social Media Era
NeuroFrontiers
Diagnosing Adult ADHD in the Social Media Era
Jill RachBeisel, MD
- Jill RachBeisel, MD
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
NeuroFrontiers
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Jill RachBeisel, MD
- Jill RachBeisel, MD

Programs

More Than a Myopathy: The Lived Experience of TK2d
More Than a Myopathy: The Lived Experience of TK2d
NeuroFrontiers
More Than a Myopathy: The Lived Experience of TK2d
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
NeuroFrontiers
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast Replay
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD; David Weisman, MD
1.00 credit
- Dani Cabral, MD
- David Weisman, MD
1.00 credit
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
MinuteCE®
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits